Answers are grounded in this paper and cite their sources.
Global enterovirus (EV) surveillance has long relied on RD/L20B cell culture systems optimized for poliovirus (PV) detection. This systematically under-detected Enterovirus coxsackiepol (EV-C) while over-representing Enterovirus betacoxsackie (EV-B). This bias created a fundamental paradox: circulating vaccine-derived polioviruses (cVDPVs), including those of novel oral polio vaccine type 2 origin, have genomic regions of non-polio EV-C origin, suggesting frequent recombination with viruses rarely detected in surveillance datasets. Here, we show that EV-C viruses might be more prevalent and widely distributed than recognized. We further show that regions considered low risk for cVDPV emergence (especially those using only inactivated PV vaccine and acute flaccid paralysis surveillance) may harbor undetected non-polio EV-C circulation and silent PV transmission. We propose integrating wastewater (WW) surveillance, long-range reverse transcription-PCR (amplifying the complete or coding-complete genome as a single contig), and long-read sequencing to capture full EV diversity, improve cVDPV emergence risk assessment, and strengthen PV-eradication efforts. Expanding this framework to other viruses can facilitate the 100-day mission by enabling the acquisition of actionable intelligence for all such viruses directly from WW. Furthermore, this creates an opportunity to harmonize PV surveillance with broader pandemic preparedness frameworks, allowing investments in PV genomic surveillance to generate cross-pathogen benefits.
No takes yet. Share an insight, caveat, or question.
Faleye et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: